Neupath Health Announces Issuance of Stock Options
TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, announced today that, in relation to the executive changes announced on July 25, 2022, a grant of 965,000 stock options (“Options”) to certain officers of the Company at an exercise price of $0.30 … [Read more…]
